Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Til Menge

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Neurological Disorders|April 2, 2021
Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world studyTil Menge, Karin Rehberg-Weber, Kirsi Taipale, et al.
European Journal of Immunology|October 6, 2007
Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISATil Menge, Hans-Christian von Büdingen, Patrice H Lalive, et al.
Journal of Neuroinflammation|November 19, 2011
Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosisTil Menge, Patrice H Lalive, H Christian von Büdingen, et al.
Immunogenetics|March 11, 2006
Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitisH-Christian von Büdingen, Til Menge, Stephen L Hauser, et al.
Current Opinion in Neurology|May 15, 2007
Acute disseminated encephalomyelitis: an acute hit against the brainTil Menge, Bernd C Kieseier, Stefan Nessler, et al.
CNS Drugs|January 4, 2023
Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive DiseaseNikolaos G Dimitriou, Sven G Meuth, Elena H Martinez-Lapiscina, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2007
Apoptotic effects of Human Herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunityJennifer L Gardell, Paul Dazin, Janeen Islar, et al.
Journal of Neuroscience Research|January 10, 2002
Osteopontin: a novel axon-regulated Schwann cell geneSebastian Jander, Simona Bussini, Eva Neuen-Jacob, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosisTil Menge, Patrice H Lalive, Hans-Christian von Büdingen, et al.
European Journal of Immunology|July 20, 2004
Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelinationHans-Christian von Büdingen, Stephen L Hauser, Jean-Christophe Ouallet, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Neurological Disorders|April 2, 2021
Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world studyTil Menge, Karin Rehberg-Weber, Kirsi Taipale, et al.
European Journal of Immunology|October 6, 2007
Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISATil Menge, Hans-Christian von Büdingen, Patrice H Lalive, et al.
Journal of Neuroinflammation|November 19, 2011
Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosisTil Menge, Patrice H Lalive, H Christian von Büdingen, et al.
Immunogenetics|March 11, 2006
Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitisH-Christian von Büdingen, Til Menge, Stephen L Hauser, et al.
Current Opinion in Neurology|May 15, 2007
Acute disseminated encephalomyelitis: an acute hit against the brainTil Menge, Bernd C Kieseier, Stefan Nessler, et al.
CNS Drugs|January 4, 2023
Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive DiseaseNikolaos G Dimitriou, Sven G Meuth, Elena H Martinez-Lapiscina, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 6, 2007
Apoptotic effects of Human Herpesvirus-6A on glia and neurons as potential triggers for central nervous system autoimmunityJennifer L Gardell, Paul Dazin, Janeen Islar, et al.
Journal of Neuroscience Research|January 10, 2002
Osteopontin: a novel axon-regulated Schwann cell geneSebastian Jander, Simona Bussini, Eva Neuen-Jacob, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2005
Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosisTil Menge, Patrice H Lalive, Hans-Christian von Büdingen, et al.
European Journal of Immunology|July 20, 2004
Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelinationHans-Christian von Büdingen, Stephen L Hauser, Jean-Christophe Ouallet, et al.
Pageof 5